000			04488nam a22004215i 4500
999			_c368774 _d368774 _x1
001			368774
003			ES-MaUEC
005			20230102121807.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			220203s2022 sz | s |||| 0|eng d
020			_a9783030886868
024	7		_a10.1007/978-3-030-88686-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC900 _b2022 EB
245	0	4	_aThe Paris System for Reporting Urinary Cytology _cedited by Eva M. Wojcik, Daniel F.I. Kurtycz, Dorothy L. Rosenthal
250			_aSecond edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XXI, 329 páginas) _b217 ilustraciones, 200 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aPathogenesis of Urothelial Carcinoma -- Adequacy of Urine Specimens (Adequacy) -- Negative for High-Grade Urothelial Carcinoma (Negative) -- Atypical Urothelial Cells (AUC) -- Suspicious for High-Grade Urothelial Carcinoma (Suspicious) -- High-Grade Urothelial Carcinoma (HGUC) -- Low-Grade Urothelial Neoplasia (LGUN) -- Cytology of the Upper Urinary Tract -- Other Malignancies Primary and Metastatic and Miscellaneous Lesions -- Ancillary Studies in Urinary Cytology -- Cytopreparatory Techniques -- Risk of Malignancy (ROM) and Clinical Management.
520			_aThe first edition of The Paris System for Reporting Urinary Cytology introduced a completely new paradigm for detecting bladder cancer by urine cytology. This system concentrated on defining morphological characteristics of the most clinically significant form of bladder cancer, High Grade Urothelial Carcinoma. This new approach has been widely accepted throughout the world, and has become part of the daily practice of cytology. Considering that the first edition of The Paris System (TPS) introduced a new model of urinary cytodiagnosis, verification and expansion of initial material and data were anticipated. Based on evolving knowledge and readership requests, the group of highly experienced authors have created a new edition of TPS. This second edition includes areas and issues not originally covered. A new chapter on urine cytology of the upper tract, a rarely addressed topic, has been introduced. Furthermore, the issue of cellular degeneration is discussed in the criteria of all diagnostic categories. Examples of standardized reports are included in each chapter. Most importantly, a separate chapter presents data defining the risk of malignancy (ROM) for each diagnostic category to inform clinical management. New high quality images augment those of the first edition to better illustrate diagnostic clues and potential pitfalls. In addition to chapters on diagnostic criteria, current concepts of pathogenesis of bladder cancer, specimen adequacy and preparation, and ancillary tests are covered in separate chapters. A bonus to the volume is a comprehensive history of urine as the earliest diagnostic sample of human disease, richly illustrated with artworks from major museums. Written by internationally recognized authorities, this comprehensive and evidence-based guide to urine cytology is supported by the newest data confirming the original concept and significance of diagnostic criteria defining High Grade Urothelial Carcinoma. TPS is an essential tool for anyone who is practicing urinary cytology, including cytotechnologists, pathologists-in-training and practicing pathologists. This book should find a place in every cytology laboratory throughout the world. The Concept has been endorsed by the American Society of Cytopathology, and the International Academy of Cytology.
988			_aSpringer_Medicine_2022
650		7	_2embne _9189633 _aAparato urinario _xEnfermedades
650		7	_2embne _9139477 _aCitología
700	1		_aWojcik, Eva M. _eeditor literario
700	1		_aKurtycz, Daniel F. I. _eeditor literario
700	1		_aRosenthal, Dorothy L. _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-88686-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b04/2022 _dz _eu _zSI